Supplementary Materials

The PDF file includes:

  • Materials and Methods
  • Fig. S1. Association of TAU with the clinical pathology of diffuse gliomas.
  • Fig. S2. Expression of TAU in PDX.
  • Fig. S3. TAU correlates with the presence of IDH mutations.
  • Fig. S4. The expression of MAPT is associated with the IDH mut DNA methylation phenotype.
  • Fig. S5. Association of TAU function with the EGFR pathway in gliomas.
  • Fig. S6. Association of TAU with the different GBM subtypes and the NF-κB–TAZ axis.
  • Fig. S7. Vascular phenotypes associated with TAZ in gliomas.
  • Fig. S8. Implication of the tumor-derived pericytes on the glioma vasculature and growth.
  • Fig. S9 TAU negatively correlates with EGFR signaling and CD248 expression.
  • Fig. S10. The vascular phenotype of gliomas is determined by the genetic status of EGFR and IDH and by the expression of TAU.
  • Table S1. Human samples.
  • Table S2. Paired human samples.
  • Table S3. GBM cell lines.
  • Table S4. Antibodies.
  • Table S5. qRT-PCR primers.
  • Table S6. Sequencing primers.
  • Legend for data file S1

[Download PDF]

Other Supplementary Material for this manuscript includes the following: